Oncomine Tumor Mutation Burden TMB Test sale cost 8400 AED
Genome Signature HRD Test sale cost 54000 AED Genome Signature HRD Test Cost 72,000 د.إ Original price was: 72,000 د.إ.54,000 د.إCurrent price is: 54,000 د.إ.
Glucose-6-Phosphate Dehydrogenase G6PD Full-Length Gene Sequence Analysis Test sale cost 9010 AED Glucose-6-Phosphate Dehydrogenase G6PD Full-Length Gene Sequence Analysis Test Cost 10,010 د.إ Original price was: 10,010 د.إ.9,010 د.إCurrent price is: 9,010 د.إ.
Sale!

Oncomine Tumor Mutation Burden TMB Test Cost

Original price was: 11,200 د.إ.Current price is: 8,400 د.إ.

-25%

The Oncomine Tumor Mutation Burden (TMB) Test is a cutting-edge genomic profiling tool designed to evaluate the mutation burden within a tumor’s DNA. This comprehensive assessment is performed at DNA Labs UAE, a leading facility in genomic and molecular diagnostics. The test specifically quantifies the number of mutations per megabase of DNA in a tumor sample, providing crucial insights that can guide personalized cancer treatment strategies.

With a cost of 8400 AED, the Oncomine TMB Test stands as a valuable investment for patients and healthcare providers seeking to optimize cancer therapy. By identifying the tumor mutation burden, this test can help predict response to certain immunotherapies, making it a key component in the management of various cancer types. The results from the Oncomine TMB Test enable clinicians to tailor treatment plans more effectively, potentially improving patient outcomes in the rapidly evolving field of oncology.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Oncomine Tumor mutation Burden TMB Test

Test Name: Oncomine Tumor mutation Burden TMB Test

Components: Paraffin embedded tissue blocks

Price: 8400.0 AED

Sample Condition: Tumor tissue

Report Delivery: 2-3 weeks

Method: NGS (Next-Generation Sequencing)

Test type: Genetics

Doctor: General Physician

Test Department: DNA Labs UAE

Pre Test Information

Oncomine Tumor mutation Burden (TMB) can be done with a doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

Oncomine Tumor Mutation Burden (TMB) is a genomic biomarker that measures the number of somatic mutations within the coding region of a tumor genome. It is a quantitative measure of the number of mutations that a tumor has accumulated, which is often associated with the immune response to the tumor.

A high TMB indicates a high mutation rate, which may lead to the production of neoantigens that can be recognized by the immune system. TMB is a promising biomarker for predicting response to immunotherapy and has been shown to be a better predictor of response than PD-L1 expression in some cases.

The Oncomine TMB assay is a next-generation sequencing-based assay that provides a standardized, accurate, and reproducible measurement of TMB across multiple tumor types.

Test Name Oncomine Tumor mutation Burden TMB Test
Components Paraffin embedded tissue blocks
Price 8400.0 AED
Sample Condition Tumor tissue
Report Delivery 2-3 weeks
Method NGS
Test type Genetics
Doctor General Physician
Test Department:
Pre Test Information Oncomine Tumor mutation Burden (TMB) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

Oncomine Tumor Mutation Burden (TMB) is a genomic biomarker that measures the number of somatic mutations within the coding region of a tumor genome. It is a quantitative measure of the number of mutations that a tumor has accumulated, which is often associated with the immune response to the tumor. A high TMB indicates a high mutation rate, which may lead to the production of neoantigens that can be recognized by the immune system. TMB is a promising biomarker for predicting response to immunotherapy and has been shown to be a better predictor of response than PD-L1 expression in some cases. The Oncomine TMB assay is a next-generation sequencing-based assay that provides a standardized, accurate, and reproducible measurement of TMB across multiple tumor types.

SKU: TEST-700 Category:

Related products